Related Experiment Video

Updated: Aug 7, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
10:51

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on: November 15, 2013

Nuclear hormone receptor variants: their role in malignancy and progression to hormone resistance in cancer

M Sluyser1

  • 1Division of Tumor Biology, The Netherlands Cancer Institute, Amsterdam.

Anti-Cancer Drugs
|December 1, 1990
PubMed

Insights

Mutations can make estrogen receptors (ERs) activate genes without estrogen, potentially driving breast cancer growth. New therapies may need to target these mutated ERs to control tumors.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Steroid and thyroid hormone receptors regulate gene transcription.
  • Mutations can lead to constitutive activation, independent of hormone binding.
  • Estrogen receptor (ER) mutations are implicated in some breast carcinomas.

Purpose of the Study:

  • To investigate the role of mutated estrogen receptors in hormone-independent gene activation.
  • To understand the implications of ER mutations for breast cancer growth and estrogen dependence.
  • To inform the development of novel therapeutic strategies against ER-mutated breast cancers.

Main Methods:

  • Analysis of mutations in functional domains of hormone receptors.
  • Investigating transcriptional activity of wild-type versus mutated ERs.
  • Correlating ER activity with gene transcription and tumor growth regulatory pathways.

Main Results:

  • Mutations render hormone receptors constitutive transactivators.
  • ER mutations can lead to estrogen-independent activation of growth regulatory genes.
  • Tumor growth may depend on the functionality of mutated ERs, not just their presence.

Conclusions:

  • Constitutive ER activity due to mutations is a key factor in some breast cancers.
  • Estrogen independence of tumor growth can be driven by ER mutants.
  • Targeting mutated ERs is crucial for effective breast cancer therapy.

More Related Videos

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Related Concept Videos

Intracellular Hormone Receptors01:08

Intracellular Hormone Receptors

Lipid-soluble hormones diffuse across the plasma and nuclear membrane of target cells to bind to their specific intracellular receptors. These receptors act as transcription factors that regulate gene expression and protein synthesis in the target cell
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...